메뉴 건너뛰기




Volumn 16, Issue 12, 2009, Pages 3227-3236

Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN;

EID: 71549118543     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0706-z     Document Type: Article
Times cited : (111)

References (19)
  • 2
    • 15944365867 scopus 로고    scopus 로고
    • Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion
    • DOI 10.1002/bjs.4695
    • Y Yonemura T Kawamura E Bandou S Takahashi T Sawa N Matsuki 2005 Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion Br J Surg 92 3 370 375 10.1002/bjs.4695 1:STN:280:DC%2BD2M7hslyhtQ%3D%3D 15739249 (Pubitemid 40445602)
    • (2005) British Journal of Surgery , vol.92 , Issue.3 , pp. 370-375
    • Yonemura, Y.1    Kawamura, T.2    Bandou, E.3    Takahashi, S.4    Sawa, T.5    Matsuki, N.6
  • 4
    • 0037090686 scopus 로고    scopus 로고
    • Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
    • DOI 10.1200/JCO.2002.08.105
    • P Ross M Nicolson D Cunningham, et al. 2002 Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer J Clin Oncol 20 8 1996 2004 10.1200/JCO.2002.08.105 1:CAS:528: DC%2BD38XjvVKmsrw%3D 11956258 (Pubitemid 34413593)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.8 , pp. 1996-2004
    • Ross, P.1    Nicolson, M.2    Cunningham, D.3    Valle, J.4    Seymour, M.5    Harper, P.6    Price, T.7    Anderson, H.8    Iveson, T.9    Hickish, T.10    Lofts, F.11    Norman, A.12
  • 5
    • 40749153540 scopus 로고    scopus 로고
    • S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
    • 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
    • W Koizumi H Narahara T Hara, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 3 215 221 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
    • (2008) Lancet Oncol , vol.9 , Issue.3 , pp. 215-221
    • Koizumi, W.1    Narahara, H.2    Hara, T.3
  • 6
    • 33745726677 scopus 로고    scopus 로고
    • Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    • 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D 16822992
    • D Cunningham W Allum S Stenning, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 1 11 20 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D 16822992
    • (2006) N Engl J Med , vol.355 , Issue.1 , pp. 11-20
    • Cunningham, D.1    Allum, W.2    Stenning, S.3
  • 7
    • 35848968863 scopus 로고    scopus 로고
    • Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial
    • V Boige J Pignon B Saint-Aubert P Lasser T Conroy O Bouche 2007 Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial J Clin Oncol 25 4510
    • (2007) J Clin Oncol , vol.25 , pp. 4510
    • Boige, V.1    Pignon, J.2    Saint-Aubert, B.3    Lasser, P.4    Conroy, T.5    Bouche, O.6
  • 8
    • 33745096894 scopus 로고    scopus 로고
    • Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination
    • 10.1007/s10120-006-0369-4 1:CAS:528:DC%2BD28XlsV2kurg%3D 16767369
    • S Satoh S Hasegawa N Ozaki, et al. 2006 Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination Gastric Cancer 9 2 129 135 10.1007/s10120-006-0369-4 1:CAS:528:DC%2BD28XlsV2kurg%3D 16767369
    • (2006) Gastric Cancer , vol.9 , Issue.2 , pp. 129-135
    • Satoh, S.1    Hasegawa, S.2    Ozaki, N.3
  • 9
    • 36849055701 scopus 로고    scopus 로고
    • A phase II study of preoperative chemotherapy (CX) with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancer: JCOG 0210
    • K Fujitani M Sasako Y Iwasaki, et al. 2007 A phase II study of preoperative chemotherapy (CX) with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancer: JCOG 0210 J Clin Oncol 25 4609
    • (2007) J Clin Oncol , vol.25 , pp. 4609
    • Fujitani, K.1    Sasako, M.2    Iwasaki, Y.3
  • 10
    • 33748543944 scopus 로고    scopus 로고
    • Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer
    • 1:CAS:528:DC%2BD28XptFWgu74%3D 16820916
    • T Oshima R Yamada S Hatori C Kunisaki T Imada 2006 Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer Oncol Rep 16 2 361 366 1:CAS:528:DC%2BD28XptFWgu74%3D 16820916
    • (2006) Oncol Rep , vol.16 , Issue.2 , pp. 361-366
    • Oshima, T.1    Yamada, R.2    Hatori, S.3    Kunisaki, C.4    Imada, T.5
  • 11
    • 33750242993 scopus 로고    scopus 로고
    • Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer
    • DOI 10.1159/000096002
    • S Ishizone F Maruta H Saito, et al. 2006 Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer Chemotherapy 52 6 301 307 10.1159/000096002 1:CAS:528:DC%2BD28XhtV2rs7bF 17008790 (Pubitemid 44608668)
    • (2006) Chemotherapy , vol.52 , Issue.6 , pp. 301-307
    • Ishizone, S.1    Maruta, F.2    Saito, H.3    Koide, N.4    Sugiyama, A.5    Nakayama, J.6    Miyagawa, S.7
  • 12
    • 3142512503 scopus 로고    scopus 로고
    • Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin
    • 10.1007/s10120-004-0281-8 15224201
    • Y Akatsu Y Saikawa T Kubota, et al. 2004 Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin Gastric Cancer 7 2 128 133 10.1007/s10120-004-0281-8 15224201
    • (2004) Gastric Cancer , vol.7 , Issue.2 , pp. 128-133
    • Akatsu, Y.1    Saikawa, Y.2    Kubota, T.3
  • 13
    • 0003192645 scopus 로고    scopus 로고
    • Japanese classification of gastric carcinoma
    • Japanese Gastric Cancer Association 2nd English ed
    • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English ed. Gastric Cancer. 1998;1(1):10-24.
    • (1998) Gastric Cancer , vol.1 , Issue.1 , pp. 10-24
  • 14
    • 71549146023 scopus 로고
    • Cancer JRSfG
    • 1st English ed. Tokyo: Kanehira Shuppan
    • Cancer JRSfG. The general rules for gastric cancer study, 1st English ed. Tokyo: Kanehira Shuppan; 1995.
    • (1995) The General Rules for Gastric Cancer Study
  • 15
    • 0028199743 scopus 로고
    • Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis
    • 1:STN:280:DyaK2czjtlykug%3D%3D 8056398
    • F Gilly P Carry A Sayag, et al. 1994 Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis Hepatogastroenterology 41 2 124 129 1:STN:280:DyaK2czjtlykug%3D%3D 8056398
    • (1994) Hepatogastroenterology , vol.41 , Issue.2 , pp. 124-129
    • Gilly, F.1    Carry, P.2    Sayag, A.3
  • 16
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
    • P Therasse S Arbuck E Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
    • (2000) J Natl Cancer Inst , vol.92 , Issue.3 , pp. 205-216
    • Therasse, P.1    Arbuck, S.2    Eisenhauer, E.3
  • 17
    • 0036569580 scopus 로고    scopus 로고
    • TNM residual tumor classification revisited
    • DOI 10.1002/cncr.10492
    • C Wittekind C Compton F Greene L Sobin 2002 TNM residual tumor classification revisited Cancer 94 9 2511 2516 10.1002/cncr.10492 12015777 (Pubitemid 34457134)
    • (2002) Cancer , vol.94 , Issue.9 , pp. 2511-2516
    • Wittekind, C.1    Compton, C.C.2    Greene, F.L.3    Sobin, L.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.